Red Light Therapy for Hair Loss in Norway
Share
Red Light Therapy for Hair Loss: What Actually Happens
Red light therapy (rødlysterapi) at wavelengths around 630nm to 660nm has been shown in multiple double-blind randomised controlled trials to significantly increase hair density in both men and women with androgenetic alopecia (pattern hair loss). It is not a miracle. It will not regrow hair where follicles are already dead. But in early to mid-stage hair thinning, the clinical evidence is solid enough that dermatologists are now recommending it as a non-pharmaceutical adjunct. Here is the honest version of how it works and what to expect.
There is a particular kind of quiet despair that happens in the shower. You look at what is in your hand, or what is in the drain, and you do a quick calculation you would rather not be doing. And then you do it again the next day. And the day after.
Hair loss (hårtap) is one of those things that is dismissed constantly as cosmetic, as vanity, as something you should just accept. And maybe eventually you do accept it. But before you get there, it is worth knowing what is actually happening at the follicular level, and whether there is anything with real science behind it that might slow things down.
I started looking more seriously at the hair loss research about three years ago, partly because customers were asking and partly because, well... I am now over 40 so one must keep a check! The quantum biology angle is actually genuinely interesting here. It is not just a light shining on your head hoping something happens. There is a specific cellular mechanism, and it is the same one underpinning most of the other photobiomodulation research. That makes it easier to evaluate critically.
What Androgenetic Alopecia Actually Is
Before we get to the light, let me give you 60 seconds on the biology of why hair thins in the first place.
Androgenetic alopecia - male or female pattern hair loss - is not primarily about losing hair. It is about the hair growth cycle shortening. Hair follicles cycle through growth (anagen), transition (catagen), and rest (telogen). In a healthy follicle, anagen runs for 2 to 7 years. In a thinning follicle, it progressively shortens to weeks or months. Hairs get finer with each cycle and eventually, if the miniaturisation continues far enough, the follicle produces nothing visible at all.
The driver of this process in genetically susceptible individuals is dihydrotestosterone (DHT), a testosterone metabolite that binds to receptors in the dermal papilla cells at the base of the follicle. This binding progressively miniaturises the follicle. It is a mitochondrial story too, as most things turn out to be: the dermal papilla cells that are shrinking are doing so partly because their energy production is compromised under DHT signalling.
The 2025 systematic review and meta-analysis published in the Journal of Cosmetic Dermatology (covering 63 studies from 2020 to 2025) found that LLLT improves hair density and follicular responsiveness in androgenetic alopecia, with enhanced outcomes when combined with topical treatments like minoxidil. For telogen effluvium (stress-related or postpartum shedding), it shows potential in prolonging anagen. The authors note that standardised protocols and long-term data are still limited. That is honest, and worth bearing in mind.
The Follicular Mitochondria Story
This is the part that most hair loss content completely misses, and it is the part that actually makes sense of why red light might work here.
Your hair follicles are among the most metabolically active structures in the human body. The matrix cells at the base of the follicle divide faster than almost any other cell type during active growth, and all that cell division requires a serious supply of ATP. Mitochondrial function inside the follicle is central to how long and vigorously the anagen phase runs.
When dermal papilla cells are under DHT-induced stress, mitochondrial function in those cells declines. ATP availability drops. The signals downstream that sustain the anagen phase become harder to maintain. The follicle shortens its growth phase partly because it has less cellular energy to sustain it.
Red and near-infrared light at the relevant wavelengths — particularly in the 630nm to 660nm range for superficial follicular tissue — is absorbed by cytochrome c oxidase in the mitochondria of those follicular cells. This stimulates ATP production, reduces reactive oxygen species, and improves the redox environment in exactly the cells whose energy supply is being throttled by the DHT process. You are not blocking DHT. But you may be partially compensating for what DHT does to the mitochondria inside the follicle.
The 2021 RNA sequencing study published in Annals of Dermatology (PMC8577899) cultured human hair follicles from patients with androgenetic alopecia and treated them with 650nm red light. The light promoted proliferation of follicular cells, prolonged the anagen phase in culture, and the researchers identified specific gene expression changes in Wnt/beta-catenin signalling pathways — one of the key molecular systems that regulates follicular cycling. This is not animals and it is not vague mechanism. It is human follicular tissue, with identified molecular targets.
What the RCTs Show
Two randomised controlled trials using the same double-blind design deserve specific mention, because they are among the cleanest data in the hair loss light therapy literature.
The trials, registered on ClinicalTrials.gov (NCT01437163), used a laser and LED helmet delivering 655nm light at 67 J/cm2, treated every other day for 16 weeks. In the male trial (Lanzafame et al., published in Lasers in Surgery and Medicine), LLLT at 655nm significantly improved hair counts compared to placebo. In the female trial, the same protocol produced similar results, with hair counts improving significantly in the active group and the authors concluding that LLLT at 655nm significantly improved hair counts in women with androgenetic alopecia at a rate similar to that observed in males.
A 2024 study in Photodermatology, Photoimmunology and Photomedicine (Tantiyavarong et al., Thammasat University) used an LED helmet over 6 months and demonstrated notable improvements in hair density and diameter in both male and female participants with androgenetic alopecia, with high patient satisfaction.
A large observational study involving over 1,300 users of helmet-type devices showed approximately 80% self-reported effectiveness after several months of consistent use.
This is not one small hopeful pilot study. There is a consistent pattern across multiple independent trials that points in the same direction: 630nm to 660nm light, applied consistently to the scalp over 3 to 6 months, improves hair density in people with early to mid-stage androgenetic alopecia.
What It Will Not Do
I need to be straight with you here, because there is a lot of wishful-thinking content in this space.
If you are at the stage where the follicles are truly gone — where the skin on your scalp is smooth and shiny and has been that way for years — red light therapy is not going to grow new follicles from nothing. The matrix cells are no longer there. There is no mitochondrial function to stimulate. The window for this intervention is while miniaturisation is still in progress and the follicles, though compromised, are still producing something.
It also does not work at the speed most people want. The trials showing meaningful results used 16 weeks to 6 months of consistent treatment, multiple times per week. Hair cycling is slow. You need to stay in anagen for longer to see denser growth. That takes time. If you quit after 6 weeks because you have not seen dramatic changes, you have not given the mechanism enough time to show itself.
And it works best on the scalp, specifically. Near-infrared light penetrates scalp tissue well. The dermal papilla cells are at the base of the follicle, below the epidermis, but still accessible. This is different from trying to reach mitochondria in deep muscle or bone.
The Norway Dimension
Here is something that almost nobody writing about hair loss and light therapy mentions, and it is specific to those of us in Norway.
Hair cycling is influenced by circadian biology and seasonal light patterns. This is documented in animals and there are suggestions it applies in humans too. There is also the broader systemic picture: melatonin, which is heavily suppressed during mørketid by indoor LED overexposure, is a potent antioxidant in follicular tissue specifically. Dr. Russel Reiter's research on melatonin extends to skin and follicular protection. When melatonin is chronically low, the oxidative environment inside follicles worsens. Combined with the mitochondrial stress of DHT, this is not a helpful combination.
For us in Norway going into and through the dark months — from October onward — the photonic environment is particularly poor in the wavelengths that support follicular mitochondrial function. The sun simply does not deliver meaningful red and near-infrared to our scalps through October to March at northern latitudes. This is not a reason to panic, but it is a reason why adding a targeted light source during those months is more than a biohack. It is compensating for something that our biology expected and is not getting.
If you want to explore the panels and portable devices we carry, the relevant wavelengths are in the red range (around 630nm to 660nm) as well as near-infrared, and you can see the full range at our red light therapy panels collection. For scalp-targeted work specifically, the portable and specialist devices give you more precision without needing to treat your whole body to get light to your head.
The honest summary is this: if you catch it early enough, and you are consistent enough, and you have realistic expectations about timescales, there is real clinical evidence that red light at the right wavelengths supports hair follicle health and slows miniaturisation in androgenetic alopecia. It is not going to replace minoxidil or a hair transplant if you are already at an advanced stage. But as a non-pharmaceutical, low-risk tool with solid mechanistic grounding and multiple positive RCTs, it is significantly more credible than most of the things being sold for hair loss in 2026.
References
Lanzafame RJ, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers in Surgery and Medicine. 2013;45(8):487-495. PubMed
Lanzafame RJ, et al. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers in Surgery and Medicine. 2014;46(8):601-607. PubMed
Tantiyavarong J, et al. Red and Green LED Light Therapy: A Comparative Study in Androgenetic Alopecia. Photodermatology, Photoimmunology and Photomedicine. 2024;40(6):e13004. PubMed
The Use of Light-Based Therapies in the Treatment of Alopecia: systematic review covering 63 studies 2020-2025. Journal of Cosmetic Dermatology. 2025. PMC Full Text
Hair Growth Promoting Effects of 650nm Red Light on Human Hair Follicles: RNA Sequencing Analysis. Annals of Dermatology. 2021. PMC Full Text
FAQ — Red Light Therapy and Hair Loss
Does red light therapy actually grow hair? Multiple double-blind randomised controlled trials show it significantly increases hair density in androgenetic alopecia (pattern hair loss) in both men and women. The key mechanism is mitochondrial stimulation in follicular cells, which supports the energy supply those cells need to sustain the anagen growth phase. It works best in early to mid-stage thinning where follicles are miniaturising but not yet gone.
What wavelength is best for hair loss? The strongest clinical evidence sits in the 630nm to 660nm range for scalp penetration and follicular stimulation. Near-infrared wavelengths (810nm to 850nm) penetrate more deeply but the follicle targets are relatively superficial, so the 650nm region is where most of the RCT evidence lies.
How long before I see results? The clinical trials showing meaningful results used 16 weeks to 6 months of consistent treatment, every other day or multiple times per week. Hair cycling is slow. Expect 3 to 4 months before meaningful density changes become visible, with continued improvement to the 6-month mark. Consistency matters far more than any individual session.
Can I use a full-body panel for my scalp, or do I need a specific device? You can use a full-body panel angled toward your head, bare scalp, at close range. The wavelengths are the same. Specialist scalp devices (caps, combs) are specifically designed for the geometry of scalp treatment, but a good panel with appropriate wavelengths and close positioning will also deliver photons to follicular tissue. Ask me what makes sense for your specific situation.
Hjelper rødlysterapi mot hårtap? Flere randomiserte kontrollerte studier viser at rødlysterapi (rødlysterapi/fotobiomodulasjon) i bølgelengder rundt 630-660 nm øker hårtetthet signifikant hos personer med androgenetisk alopeci. Effekten er best i tidlige til midtre stadier av hårtap, der hårsekkene fortsatt er aktive men miniaturiserte. Tidlig behandling gir bedre resultater enn å vente.
Virker rødlysterapi for kvinner med hårtap? Ja. Kliniske studier (NCT01437163) viste tilsvarende resultater hos kvinner som hos menn, ved bruk av samme protokoll. Kvinner opplever hårtap av andre årsaker enn menn, inkludert telogen effluvium (stressutløst og etter fødsel), der studier viser at rødlysterapi kan forlenge vekstfasen og redusere hårfall.
Hva skjer med hårsekker i Norge om vinteren? Lysunderskuddet under mørketid betyr at hodebunnen ikke mottar de rød- og nær-infrarøde bølgelengdene som hårsekkenes mitokondrier er utviklet til å bruke. Kombinert med lavere melatoninnivåer fra LED-eksponering innendørs forverres det oksidative miljøet i hårsekkene. Rødlysterapi gjennom disse månedene kompenserer for et lysunderskudd som din biologi ikke er tilpasset.
Disclaimer: This post is for informational and educational purposes only and does not constitute medical advice. If you have concerns about hair loss, please consult a qualified dermatologist or healthcare professional. Red light therapy devices are general wellness tools and are not medical devices.